LSL Pharma Group Inc. LSL.V
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -5.32M | -3.98M | -- | -- | -- |
| Total Depreciation and Amortization | 2.34M | 2.08M | -- | -- | -- |
| Total Amortization of Deferred Charges | 4.30K | 4.30K | -- | -- | -- |
| Total Other Non-Cash Items | 1.37M | 1.04M | -- | -- | -- |
| Change in Net Operating Assets | -2.68M | -3.16M | -- | -- | -- |
| Cash from Operations | -4.28M | -4.02M | -- | -- | -- |
| Capital Expenditure | -1.34M | -1.37M | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -1.79M | -1.79M | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -2.63M | -2.36M | -- | -- | -- |
| Cash from Investing | -5.77M | -5.52M | -- | -- | -- |
| Total Debt Issued | 24.69M | 28.58M | -- | -- | -- |
| Total Debt Repaid | -13.34M | -13.39M | -- | -- | -- |
| Issuance of Common Stock | 2.32M | 2.32M | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -3.82M | -3.75M | -- | -- | -- |
| Cash from Financing | 7.14M | 9.95M | -- | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.91M | 412.40K | -- | -- | -- |